CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,728,000 | 4,586,000 | 8,368,000 | 4,327,000 | 7,989,000 |
| Depreciation Amortization | 10,331,000 | 4,597,000 | 4,366,000 | 4,224,000 | 4,917,000 |
| Income taxes - deferred | 102,000 | -572,000 | -676,000 | -2,029,000 | -402,000 |
| Accounts receivable | -3,498,000 | -1,301,000 | -6,260,000 | -2,971,000 | -2,703,000 |
| Accounts payable and accrued liabilities | 3,855,000 | 2,335,000 | 3,618,000 | 4,260,000 | 2,898,000 |
| Other Working Capital | -1,474,000 | 109,000 | 15,000 | 6,818,000 | 3,857,000 |
| Other Operating Activity | -405,000 | -647,000 | 3,995,000 | 1,548,000 | 1,709,000 |
| Operating Cash Flow | $10,639,000 | $9,107,000 | $13,426,000 | $16,177,000 | $18,265,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -9,963,000 |
| PPE Investments | -2,832,000 | -2,781,000 | -3,031,000 | -2,727,000 | -2,520,000 |
| Net Acquisitions | -436,000 | -95,000 | -16,612,000 | -1,388,000 | -146,000 |
| Purchase Of Investment | -15,012,000 | -15,191,000 | -9,043,000 | -7,746,000 | N/A |
| Sale Of Investment | 12,383,000 | 10,353,000 | 7,729,000 | 6,729,000 | 7,246,000 |
| Other Investing Activity | 26,000 | 101,000 | 68,000 | 85,000 | 122,000 |
| Investing Cash Flow | $-5,871,000 | $-7,613,000 | $-20,889,000 | $-5,047,000 | $-5,261,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,119,000 | 1,919,000 | 5,200,000 | 0 | 0 |
| Debt Issued | 3,969,000 | 7,913,000 | 10,898,000 | 0 | 987,000 |
| Debt Repayment | -3,629,000 | -4,773,000 | -3,166,000 | -4,211,000 | -10,254,000 |
| Common Stock Issued | 394,000 | 361,000 | 277,000 | 551,000 | 549,000 |
| Common Stock Repurchased | 0 | -3,023,000 | -2,012,000 | -3,500,000 | 0 |
| Dividend Paid | -3,397,000 | -3,373,000 | -3,132,000 | -2,907,000 | -2,625,000 |
| Other Financing Activity | -158,000 | -159,000 | -5,382,000 | -449,000 | -13,000 |
| Financing Cash Flow | $-4,940,000 | $-1,135,000 | $2,683,000 | $-10,516,000 | $-11,356,000 |
| Beginning Cash Position | 8,884,000 | 8,525,000 | 13,305,000 | 12,691,000 | 11,043,000 |
| End Cash Position | 8,712,000 | 8,884,000 | 8,525,000 | 13,305,000 | 12,691,000 |
| Net Cash Flow | $-172,000 | $359,000 | $-4,780,000 | $614,000 | $1,648,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,639,000 | 9,107,000 | 13,426,000 | 16,177,000 | 18,265,000 |
| Capital Expenditure | -2,832,000 | -2,781,000 | -3,031,000 | -2,727,000 | -2,520,000 |
| Free Cash Flow | 7,807,000 | 6,326,000 | 10,395,000 | 13,450,000 | 15,745,000 |